Efforts to understand the pathophysiology of ASCVD have largely relied on one of two mouse models of the disease based on genetic disruption of lipid clearance: apolipoprotein-E- and LDL receptor-deficient mice (ApoE−/− and Ldlr−/−, respectively). This evidence concerns the gene LDLR and atherosclerosis.